DBIX India Net
16.01.2006 12:35:00
|
Dr. Reddy's to Release Q3 FY06 results on January 24, 2006; Earnings Call Slated for January 24, 6:30 PM IST/8:00 AM EST
Summary of Events
Event Date and Time (IST) Medium
Release of financial January 24, after the Email, Media,
results Board Meeting Company website,
Business Wire
Earnings Call January 24, 6.30 PM Hosted by the
IST / 8.00 AM EST Company
(Details below)
Webcast of Earnings January 24, 6.30 PM URL available on
Call IST / 8.00 AM EST Company's
through April 23, 2006 website,
www.drreddys.com
Transcripts of the Within 10 working days URL available on
Earnings call of the Call Company's
website,
www.drreddys.com
Earnings Call
Following the release, the management of the Company will host anearnings call to discuss the Company's financial performance.
Date Timing Dial-in number
----------------- ---------------------- ---------------------------
January 24, 2006 India - 6.30 PM Participants from India
US EST - 8.00 AM 022.2781.2277
Stand by - 022 5591 7977
Participants from the US
1 877 209 0463
Conference ID: 4054397#
Participants outside India
& US (Singtel bridge)
65 666 87512
Conference Code: 409283#
----------------- ---------------------- ---------------------------
No password/pin number is necessary to dial in to any of the othercalls. As participation in the call is limited, early registration isencouraged. The operator will provide instructions on asking questionsbefore and during the call.
Audio Webcast
The audio webcast of the earnings call will be available to allinterested parties at www.drreddys.com. Please visit the web site atleast fifteen minutes ahead of the scheduled start time to registerand to download and install any necessary audio software. Participantsin the webcast can listen to the proceedings, but will not be able toask questions. The replay will be available 2 hours after the earningscall, through April 23, 2006.
Transcript
The transcript of the earnings call will also be available on theCompany's website within 10 workings days of the call.
About Dr Reddy's
Established in 1984, Dr. Reddy's Laboratories (NYSE:RDY) is anemerging global pharmaceutical company with proven basic researchcapabilities. The company develops, manufactures and markets a widerange of pharmaceutical products in India and overseas. Dr. Reddy'sproduces finished dosage forms, active pharmaceutical ingredients,diagnostic kits, critical care and biotechnology products. The basicresearch program of Dr. Reddy's focuses on cancer, diabetes, bacterialinfections and pain management. Website: http://www.drreddys.com
Safe Harbor
This press release includes forward-looking statements, as definedin the U.S. Private Securities Litigation Reform Act of 1995. We havebased these forward-looking statements on our current expectations andprojections about future events. Such statements involve known andunknown risks, uncertainties and other factors that may cause actualresults to differ materially. Such factors include, but are notlimited to, changes in local and global economic conditions, ourability to successfully implement our strategy, the market acceptanceof and demand for our products, our growth and expansion,technological change and our exposure to market risks. By theirnature, these expectations and projections are only estimates andcould be materially different from actual results in the future.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Indizes in diesem Artikel
DBIX India Net | 1 288,29 | -0,96% |